Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-12-158768
Filing Date
2012-04-11
Accepted
2012-04-11 15:35:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT d332419d424b5.htm 424B5 178122
  Complete submission text file 0001193125-12-158768.txt   179139
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-178656 | Film No.: 12754239
SIC: 2836 Biological Products, (No Diagnostic Substances)